Creo Medical Group PLC Stock

Equities

CREO

GB00BZ1BLL44

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. 11:35:28 2024-05-01 am EDT 5-day change 1st Jan Change
35.75 GBX -0.69% Intraday chart for Creo Medical Group PLC +2.88% -22.28%
Sales 2023 * 32.03M 40.16M Sales 2024 * 40.6M 50.9M Capitalization 125M 156M
Net income 2023 * -18M -22.57M Net income 2024 * -11M -13.79M EV / Sales 2023 * 3.2 x
Net cash position 2023 * 22.05M 27.64M Net cash position 2024 * 15.67K 19.65K EV / Sales 2024 * 3.07 x
P/E ratio 2023 *
-6.16 x
P/E ratio 2024 *
-11.1 x
Employees 279
Yield 2023 *
-
Yield 2024 *
-
Free-Float 79.37%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.69%
1 week+2.88%
Current month+4.38%
1 month+3.62%
3 months-16.47%
6 months+10.85%
Current year-22.28%
More quotes
1 week
35.00
Extreme 35
37.00
1 month
33.50
Extreme 33.5
41.00
Current year
29.12
Extreme 29.12
50.00
1 year
22.72
Extreme 22.718
50.00
3 years
19.00
Extreme 19
220.00
5 years
19.00
Extreme 19
243.00
10 years
19.00
Extreme 19
250.00
More quotes
Managers TitleAgeSince
Founder - -
Chief Executive Officer - 11-12-31
President - -
Members of the board TitleAgeSince
Chairman 59 16-06-30
Director/Board Member 60 -
Chief Executive Officer - 11-12-31
More insiders
Date Price Change Volume
24-05-01 35.75 -0.69% 154,578
24-04-30 36 0.00% 68,832
24-04-29 36 -0.69% 175,737
24-04-26 36.25 0.00% 299,147
24-04-25 36.25 +3.28% 695,375

Delayed Quote London S.E., May 01, 2024 at 11:35 am EDT

More quotes
Creo Medical Group plc is a medical device company. The Company is focused on the development and commercialization of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. It is engaged in research, development and distribution of electrosurgical medical devices relating to the field of surgical endoscopy. The Company has developed the CROMA powered by Kamaptive full-spectrum adaptive technology, which provides optimized surgical capability and patient outcomes. The Kamaptive is a seamless, intuitive integration of multi-modal energy sources. Its CROMA delivers bipolar radiofrequency (RF) energy for precise localized cutting and focused high frequency microwave (MW) energy for controlled coagulation and ablation via a single accessory port. This technology, combined with its range of patented electrosurgical devices, is designed to provide clinicians with flexible, accurate and controlled clinical solutions.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3575 GBP
Average target price
0.995 GBP
Spread / Average Target
+178.32%
Consensus

Annual profits - Rate of surprise